- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04700150
Tai Chi in Spondyloarthritis (TaiChiSpA)
Effect of Tai Chi Protocol on Global Physical Activity in Patients With Spondyloarthitis in Comparison With a Control Group
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Selection and inclusion of patients will be done by principal investigator of Rheumatology Department. After verification of inclusion and non-inclusion criteria by principal investigator and signature of consent, patients will be randomized by 1: 1 randomization (centralized randomization by statistician into 2 groups at M0). They will participate in sessions in a deferred manner due to two per week for each group:
- Interventional "A" group: 32 sessions (on average 2/week) performed from M0 to M4 in 15 patients.
- Control "B" group: 16 sessions (on average 2/week) performed from M2 to M4 in 15 patients.
Patients of "B" group will be not performing sessions with "A" group patients. Sessions lasting about 45 minutes will be proposed from Monday to Friday in a room planned from this activity within the CHU. Exercises will be adapted and personalized according to each one. Evaluations will be carried out at M0, M2 and at the end of the protocol at M4.
Assessment of pain and stress will be done before and after each session. Final assessment will be done at 4 months after randomization. Fitness assessment and tai chi sessions will be conducted by APA student.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63003
- Chu Clermont Ferrand
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient age > 18 years old with Spondyloarthitis (ASAS criteria), with activity deemed stable by rheumatologist.
- Patient able to walk without help
- Patient able to complete a questionnaire
- Patient giving informed consent.
- Patient covered by social security
Exclusion Criteria:
- Patient with disorder of higher mental function or psychiatric disorders.
- Patient who has previously contribute to a tai chi program.
- Patient with an absolute contraindication to physical activity.
- Protected populations: pregnant women, breastfeeding women, tutorship, trusteeship, deprived of liberty, safeguard of justice
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: interventional group A
2 tai chi session per week during 4 month (M0 to M4)
|
Tai chi sessions will consist of repetition of simple and basic movements focusing mainly on breathing, relaxation and body diagram.
This Chinese martial art also includes coordination exercises of body parts (legs, arms, pelvis and spine), looseness and limbering up of joints and muscles.
|
|
Placebo Comparator: Control group B
2 tai chi session per week during 2 month (M2 to M4)
|
Tai chi sessions will consist of repetition of simple and basic movements focusing mainly on breathing, relaxation and body diagram.
This Chinese martial art also includes coordination exercises of body parts (legs, arms, pelvis and spine), looseness and limbering up of joints and muscles.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in global physical activity time per week, Global Physical Activity Questionnaire
Time Frame: Month 0
|
measured by modified Global Physical Activity Questionnaire (GPAQ) .
|
Month 0
|
|
Change in global physical activity time per week, Global Physical Activity Questionnaire
Time Frame: Month 2
|
measured by modified Global Physical Activity Questionnaire (GPAQ) .
|
Month 2
|
|
Change in global physical activity time per week, measured by an accelerometer
Time Frame: Month 0
|
measured by an accelerometer between M0 and M2 expressed in MET.min/week.
|
Month 0
|
|
Change in global physical activity time per week, measured by an accelerometer
Time Frame: Month 2
|
measured by an accelerometer between M0 and M2 expressed in MET.min/week.
|
Month 2
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Physical activity time of light intensity, moderate intensity, high intensity
Time Frame: Month 0
|
measured by an accelerometer
|
Month 0
|
|
Change in Physical activity time of light intensity, moderate intensity, high intensity
Time Frame: Month 2
|
measured by an accelerometer
|
Month 2
|
|
Change in Physical activity time of light intensity, moderate intensity, high intensity
Time Frame: Month 4
|
measured by an accelerometer
|
Month 4
|
|
Change in Physical activity time of light intensity, moderate intensity, high intensity
Time Frame: Month 0
|
measured by the modified Global Physical Activity Questionnaire
|
Month 0
|
|
Change in Physical activity time of light intensity, moderate intensity, high intensity
Time Frame: Month 2
|
measured by the modified Global Physical Activity Questionnaire
|
Month 2
|
|
Change in Physical activity time of light intensity, moderate intensity, high intensity
Time Frame: Month 4
|
measured by the modified Global Physical Activity Questionnaire
|
Month 4
|
|
Change in Sedentary time
Time Frame: Month 2
|
measured by modified Global Physical Activity Questionnaire
|
Month 2
|
|
Change in Sedentary time
Time Frame: Month 4
|
measured by modified Global Physical Activity Questionnaire
|
Month 4
|
|
Change in Sedentary time
Time Frame: Month 2
|
measured by an accelerometer
|
Month 2
|
|
Change in Sedentary time
Time Frame: Month 4
|
measured by an accelerometer
|
Month 4
|
Collaborators and Investigators
Investigators
- Principal Investigator: Martin SOUBRIER, University Hospital, Clermont-Ferrand
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RBHP 2018 SOUBRIER
- 2018-A01275-50 (Other Identifier: 2018-A01275-50)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spondyloarthritis
-
University of BonnNovartis; Novartis PharmaceuticalsRecruitingAxial Spondyloarthritis | Axial and Peripheral Spondyloarthritis | Axial Spondyloarthopathy | Axial Spondyloarthritis and Ankylosing Spondylitis | Axial Spondyloarthritis (AxSpA) | Axial Spondylarthritis (r-axSpA) | Axial Spondyloarthritis, Non-RadiographicGermany
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingA Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial SpondyloarthritisActive Non-radiographic Axial SpondyloarthritisChina
-
Lingli DongNot yet recruitingNon-Radiographical Axial Spondyloarthritis | Nr-axial SpondyloarthritisChina
-
UCB Biopharma SRLCompletedNonradiographic Axial SpondyloarthritisUnited States, Belgium, Bulgaria, China, Czechia, France, Germany, Hungary, Japan, Poland, Spain, United Kingdom, Turkey (Türkiye)
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Not yet recruitingAxial Spondyloarthritis, Non-RadiographicChina
-
Novartis PharmaceuticalsActive, not recruitingNon-radiographic Axial SpondyloarthritisItaly, Germany, Thailand, Israel, Belgium, France, Hungary, Malaysia, Poland, Philippines, Colombia, Mexico, Romania, Czechia, Brazil, Netherlands, Vietnam, Turkey (Türkiye)
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...RecruitingAxial SpondyloarthritisChina
-
Merck Sharp & Dohme LLCCompletedSpondyloarthritisCzechia, Germany, Netherlands, Poland, Romania, Russian Federation, Spain, Turkey, Ukraine
-
Novartis PharmaceuticalsCompletedNon-radiographic Axial SpondyloarthritisChina
-
UCB Biopharma SRLActive, not recruitingAnkylosing Spondylitis | Axial Spondyloarthritis | r-axSpa | Nr-axSpaUnited States, Belgium, Bulgaria, China, Czechia, France, Germany, Hungary, Japan, Netherlands, Poland, Spain, United Kingdom, Turkey (Türkiye)
Clinical Trials on Tai Chi 4 month
-
Lidian ChenPeking University Third HospitalNot yet recruiting
-
Harvard University Faculty of MedicineBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompleted
-
Chengdu University of Traditional Chinese MedicineNot yet recruitingQuality of Life | Dialysis; Complications | Chinese Medicine
-
Jinan University GuangzhouChaozhou Special Education SchoolCompleted
-
Taipei Veterans General Hospital, TaiwanNational Science Council, TaiwanCompleted
-
Hartford HospitalRecruiting
-
Texas Tech University Health Sciences CenterCompleted
-
Chang Gung Memorial HospitalCompleted
-
Massachusetts General HospitalUnknown
-
Chen Li TienCompletedExercise TrainingTaiwan